| [1] |
American College of Obstetricians and Gynecologists.Gestational hypertension and preeclampsia: ACOG practice bulletin, Number 222[J]. Obstet Gynecol，2020，135(6)：e237-260.
|
| [2] |
Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens, 2022，27：148-169.
|
| [3] |
World Health Organization. WHO recommendations on drug treatment for non-severe hypertension in pregnancy[M]. Geneva: WHO, 2020：13-14.
|
| [4] |
World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia[M]. Geneva: WHO, 2011：15-19.
|
| [5] |
Garovic VD, Dechend R, Easterling T, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association[J]. Hypertension，2022，79(2)：e21-41.
|
| [6] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志，2020，55(4)：227-238.
|
| [7] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期血压管理中国专家共识(2021)[J]. 中华妇产科杂志，2021，56(11)：737-745.
|
| [8] |
中华医学会心血管病学分会女性心脏健康学组，中华医学会心血管病学分会高血压学组. 妊娠期高血压疾病血压管理专家共识(2019)[J]. 中华心血管病杂志，2020，48(3)：195-204.
|
| [9] |
中华医学会围产医学分会，中华医学会妇产科学分会产科学组. 围产期降压药物临床应用管理指南(2025年)[J]. 中华围产医学杂志，2025，28(9)：721-731.
|
| [10] |
方湘，宋海齐，廖晓阳，等. 中国妊娠期高血压疾病的管理建议：基于《2023年澳大利亚和新西兰产科医学协会妊娠期高血压疾病指南摘要》[J]. 中国全科医学，2025，28(6)：649-654.
|
| [11] |
American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period[J]. Obstet Gynecol，2019，133(2)：e174-180.
|
| [12] |
Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy[J]. Cochrane Database Syst Rev，2018，10：CD002252.
|
| [13] |
Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy[J]. N Engl J Med，2015，372(5)：407-417.
|
| [14] |
Magee LA, von Dadelszen P, Singer J, et al. The CHIPS randomized controlled trial (control of hypertension in pregnancy study): is severe hypertension just an elevated blood pressure？[J]. Hypertension，2016，68(5)：1153-1159.
|
| [15] |
Tita AT, Szychowski JM, Boggess K, et al. Treatment for mild chronic hypertension during pregnancy[J]. N Engl J Med，2022，386(19)：1781-1792.
|
| [16] |
Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy[J]. Cochrane Database Syst Rev，2013(7)：CD001449.
|
| [17] |
Sridharan K, Sequeira RP. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials[J]. Br J Clin Pharmacol，2018，84(9)：1906-1916.
|
| [18] |
Shekhar S, Gupta N, Kirubakaran R, et al. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis[J]. BJOG，2016，123(1)：40-47.
|
| [19] |
Alavifard S, Chase R, Janoudi G, et al. First-line antihypertensive treatment for severe hypertension in pregnancy: a systematic review and network meta-analysis[J]. Pregnancy Hypertens，2019，18：179-187.
|
| [20] |
Easterling T, Mundle S, Bracken H, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial[J]. Lancet，2019，394(10203)：1011-1021.
|
| [21] |
Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks′ gestation (HYPITAT): a multicentre, open-label randomised controlled trial[J]. Lancet，2009，374(9694)：979-988.
|
| [22] |
Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial[J]. Lancet，2019，394(10204)：1181-1190.
|
| [23] |
Churchill D, Duley L, Thornton JG, et al. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks′ gestation[J]. Cochrane Database Syst Rev，2018，10：CD003106.
|
| [24] |
Countouris M, Mahmoud Z, Cohen JB, et al. Hypertension in pregnancy and postpartum: current standards and opportunities to improve care[J]. Circulation，2025，151(7)：490-507.
|
| [25] |
Lopes Perdigao J, Lewey J, Hirshberg A, et al. Furosemide for accelerated recovery of blood pressure postpartum in women with a hypertensive disorder of pregnancy: a randomized controlled trial[J]. Hypertension，2021，77(5)：1517-1524.
|
| [26] |
Keen SK, Sall K, Koczo A, et al. Effects of immediate postpartum diuretic treatment on postpartum blood pressure among individuals with hypertensive disorders of pregnancy: a systematic review and meta-analysis[J]. Hypertension，2026，83(2)：e24263.
|
| [27] |
Loheit AC, Lößner C, Schleussner E, et al. Hemodynamics-guided therapy for hypertensive disorders of pregnancy: a systematic review[J]. Arch Gynecol Obstet，2026，313(1)：43.
|